Strathclyde to establish nanotechnologies facility

The Multiscale Metrology Suite (MMS) for Next-Generation Health Nanotechnologies will provide UK scientists with access to technology for the analysis of materials, supporting discovery of future diagnostics and therapies.

Enabling combined physical and chemical analysis of prototype technologies, the facility has received combined investment from Strathclyde and the EPSRC (Engineering and Physical Sciences Research Council) worth over £1.6m.

Analysis of nanotechnologies for healthcare applications is currently complex and challenging, requiring multiple technologies which often results in delays in the development of new medicines or failure of products at later clinical trial stages. 

As a modular suite combining the latest in detection technologies in a single setup, the MMS aims to push existing limitations through enabling multiple analyses to be performed on the same sample. 

Strathclyde exploring fungi to prevent landslips

Strathclyde to explore wave energy potential

Data generated from the measurements will enable researchers to improve their understanding of what properties drive the performance and safety of new nanotechnology-based medicines. Nanotechnology researchers from academia and industry can access the facility, testing new prototypes and developing new workflows.